These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3287230)

  • 1. [Endometrial changes in the presence of a progesterone-releasing IUD. Cytological evaluation].
    Cinel A; Insacco E; Minucci D
    Minerva Ginecol; 1988 Jan; 40(1):1-8. PubMed ID: 3287230
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of intrauterine contraceptive devices on the endometrium].
    Sheppard BL; Bonnar J
    Contracept Fertil Sex (Paris); 1987 Nov; 15(11):1015-24. PubMed ID: 12341565
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endometrial morphological changes in IUD users: a review.
    Sheppard BL
    Contraception; 1987 Jul; 36(1):1-10. PubMed ID: 3117492
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Histological and cytological changes in women using intrauterine contraceptive devices (author's transl)].
    Poppendiek G; Dallenbach-Hellweg G; Hettenbach A
    Geburtshilfe Frauenheilkd; 1980 Aug; 40(8):716-21. PubMed ID: 7409431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation in vivo and in vitro of cervical mucus in IUD users: differences between women wearing copper and progesterone releasing IUDs.
    Scarselli G; Noci I; Chelo E; Tantini C; Livi C
    Acta Eur Fertil; 1983; 14(4):279-82. PubMed ID: 6689512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [IUD-related anatomical, cytological and pathological modifications in the uterine tract (author's transl)].
    Levrier M
    Contracept Fertil Sex (Paris); 1982 May; 10(5):293-9. PubMed ID: 12338181
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medicated intrauterine devices: development considerations and clinical uses.
    Chien YW
    J Parenter Drug Assoc; 1980; 34(4):295-323. PubMed ID: 6902777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
    Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
    Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Progestasert system].
    Mall-Haefeli M
    Gynakol Rundsch; 1978; 18(3-4):253-62. PubMed ID: 569628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Ultrastructural changes in the endometrium of women using progesterone-releasing intrauterine devices for more than 5 years].
    González Angulo A; Aznar Ramos R
    Arch Invest Med (Mex); 1988; 19(3):319-28. PubMed ID: 3242440
    [No Abstract]   [Full Text] [Related]  

  • 11. [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)].
    Imperato F; Perniola G; Mossa B; Marziani R; Perniola F; Stragapede B; Napolitano C
    Minerva Ginecol; 2002 Jun; 54(3):271-8. PubMed ID: 12063443
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Ultrastructural endometrial changes in IUD users].
    Mainero C; Bruno V; Lombardo M; Pace S; Modesti A; Simonelli L; Vecchione A
    Patol Clin Ostet Ginecol; 1985; 13(5):399-406. PubMed ID: 12315929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Endometrial cytology and copper containing intrauterine devices].
    Herting W; Tauber PF
    Fortschr Med; 1978 Feb; 96(7):311-4. PubMed ID: 304829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of action of intrauterine devices.
    Ortiz ME; Croxatto HB; Bardin CW
    Obstet Gynecol Surv; 1996 Dec; 51(12 Suppl):S42-51. PubMed ID: 8972502
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intrauterine contraception in women over 35-years old: comparison between copper and progesterone IUDs].
    Calzolari E; Galoppi P; Masala L; Parisi C; Iannucci D; Salmaggi P; Custo GM; Zichella L
    Patol Clin Ostet Ginecol; 1985; 13(1):49-56. PubMed ID: 12342024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Intrauterine devices: reactions of the endometrium and alteration of the devices after varying time of exposure in situ (author's transl)].
    Ludwig H
    Verh Dtsch Ges Pathol; 1980; 64():523-35. PubMed ID: 7013339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Action of medicated intrauterine contraceptives on the endometrium].
    Shirokova TA; Antipova NB; Zubrikhina GN; Solomatina TP
    Lab Delo; 1981; (11):665-7. PubMed ID: 6170818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability].
    Custo GM; Cosmi EV
    Patol Clin Ostet Ginecol; 1984; 12(4):331-43. PubMed ID: 12340352
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endometrial morphology in women exposed to uterine systems releasing progesterone.
    Martínez-Manautou J; Maqueo M; Aznar R; Pharriss BB; Zaffaroni A
    Am J Obstet Gynecol; 1975 Jan; 121(2):175-9. PubMed ID: 46712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrauterine devices. The optimal long-term contraceptive method?
    Fortney JA; Feldblum PJ; Raymond EG
    J Reprod Med; 1999 Mar; 44(3):269-74. PubMed ID: 10202746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.